AMERICAN FINANCIAL GROUP, INC. (AFG): what the price requires

At today's price, AMERICAN FINANCIAL GROUP, INC. (AFG) is priced for 16.6% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/AFG

Headline

FieldValue
TickerAFG
CompanyAMERICAN FINANCIAL GROUP, INC.
Current price$143.63/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed16.6%
Return on equity now17.5%
ROE gap-0.9pp
Price-to-book2.55x

Solve inputs: computed at a 8.9% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~2.6pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.78σ
cohort percentile (of 80 peers)70
sustained it ~10 years at this level56%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.25x3expensive
Earnings0.89x2justifies
Relative1.14x3expensive
Growth1.09x2expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.

Per-Model Detail (n=10)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$162.310.88xyesTBVPS $50.02 × 3.24x (ROE (TTM) 18.8% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$122.041.18xyesP/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.7x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$238.870.60xyesStage 1: 11% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$114.081.26xyesBV/sh $56.16, ROE (TTM) 18.8%, ke 9.3%
Two-Stage Excess ReturnAsset$160.640.89xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$90.621.58xyesRev $8.2B, growth -1% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.5x / 1.7x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$126.361.14xyesEPS $10.53, growth 11% (input: historical EPS growth), PEG=1.20 (Fair)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$115.351.25xyes√(22.5 × EPS $10.53 × BVPS $56.16) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$275.850.52xyesEPS $10.53 × (8.5 + 2×11.4%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$179.730.80xyesEPS $10.53 × (PEG 1.5 × growth 11.4% (input: historical EPS growth)) → PE 17.1x
Earnings YieldEarnings$113.841.26xyesEPS $10.53 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-0.6%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

American Financial Group is a specialty property and casualty insurer, valued the way insurers should be: off the return it earns on its capital, not an operating multiple. At $132.99 the price reads as about 2.4x book, implying a sustained return on equity near 15.8%, against the roughly 17% to 18% it has recently earned.

The underwriting is running well. Q1 2026 produced a 90.3% combined ratio in specialty P&C, a 3.7-point improvement, with core net operating EPS up 36% to $2.47 and a core ROE of 17%. Book value per share was about $56.30 at quarter-end.

The shareholder-return record is the signature: AFG paid a $1.50 special dividend in February, returned about $260 million in the quarter, and exceeded $700 million in capital returns in 2025. The price is supported by the asset, earnings-power, and relative-multiple families, so this reads as a value name riding strong underwriting, with the risk being reserve adequacy and pricing discipline as the cycle matures.

Bull Case

What the standard valuation models miss about American Financial Group is the quality of the underwriting machine behind the book value. A generic frame sees a financial company at roughly 2.4x book and flags it as fully priced, but that multiple is earned: AFG runs a portfolio of specialty P&C niches where deep underwriting expertise produces consistently profitable insurance rather than the commodity coverage that dominates the industry. The Q1 2026 combined ratio of 90.3%, an improvement of 3.7 points year over year, means the company kept under 91 cents of every premium dollar in claims and expenses, generating an underwriting profit before any investment income. The filing details the granular niche structure, including specialty financial lines where management actively manages exposure (FY2025 10-K, accession 0001042046-26-000010). A 2.4x book multiple on a business earning a high-teens ROE is not expensive; it is the market correctly pricing a durable franchise.

The second pillar is the capital-return discipline that distinguishes AFG from peers. The company does not hoard excess capital; it returns it. In Q1 2026 alone AFG paid cash dividends of $2.38 per share, including a $1.50 special dividend in February, repurchased $60 million of stock at an average of $127.12, and returned nearly $260 million to shareholders in total. In 2025 capital returns exceeded $700 million. Special dividends, funded by excess capital and reserve releases when underwriting outperforms, are a hallmark of management's owner-oriented approach, and the willingness to buy back stock below the prevailing price signals confidence that the shares are worth more than the market pays. For a holder, this turns a steady insurer into a compounding cash-return vehicle.

The third pillar is the earnings momentum and the favorable backdrop. Core net operating earnings rose 36% to $2.47 per share in Q1 2026, the specialty P&C segment's underwriting profit jumped sharply, and catastrophe losses came in lower than the prior year at 2.2 points versus 4.5. Management guides 2026 to 3% to 5% premium growth and a 92.5% combined ratio, a profitable target that leaves room for the underwriting upside the first quarter showed.

Bear Case

Frame the bear case as a disagreement among the valuation methods, because here the conservative ones carry a real warning. The price sits in the upper half of the peer group's price-to-book, and several methods say the stock is already at or past fair value. The two-stage excess-return model lands near $161 but the simple excess-return model lands near $114, below the price, and the inversion is explicit that at today's price the market assumes AFG sustains a return on equity near 15.8% while paying about 2.4x book. The catch is durability: the inversion notes that historically only about 57% of firms earning this return sustained it for a decade. The bull case rests on the high-teens ROE persisting; the conservative methods are pricing the more likely fade of that return toward the cost of equity, and on that fade the stock is not cheap.

The second risk is the one inherent to all insurers and easy to underprice in a good year: reserve adequacy. An insurer's reported book value and earnings depend on estimates of future claims that have been incurred but not yet paid, and those estimates can prove too optimistic. AFG's own filing flags this directly, devoting attention to "the areas posing the greatest risk of material" misstatement and to the uncertainty in valuing its investment securities (FY2025 10-K, accession 0001042046-26-000010). A 90.3% combined ratio is excellent, but part of any quarter's underwriting result can come from releasing reserves set in prior years; if those releases reverse, or if a line like specialty financial or casualty develops adversely, the reported profitability that justifies the 2.4x multiple compresses. The special dividends that delight shareholders are themselves a sign that management is releasing capital, which is wonderful when reserves prove redundant and painful if they later prove short.

The third issue is the insurance pricing cycle and investment-income sensitivity. P&C is cyclical: when underwriting is profitable, capital floods in, competition intensifies, and pricing softens, pushing combined ratios back up. AFG's specialty niches are more defensible than commodity lines, but they are not immune, and the filing notes some lines saw gross written premiums decline modestly, a hint that growth is not uniform. On the investment side, a large insurer's earnings ride on the yield it earns on its float; a decline in interest rates would compress investment income just as a softening underwriting cycle pressures the combined ratio. The price embeds continuation of both strong underwriting and a favorable rate environment. The bear case is that the cycle turns, the ROE fades from the high teens toward the cost of equity, and the premium-to-book multiple the price requires erodes with it.

Valuation

AFG is valued on a financial frame: an insurer is worth the return it earns on its capital, so the price is read off price-to-book rather than an operating multiple. At $132.99 (June 27, 2026) the market is paying about 2.4x book and assuming a sustained ROE near 15.8%, against a company that has recently earned about 17.5%. The implied return is within reach of its own record, which is why the priced-in assumption is characterized as within range, though it sits in the upper half of the peer group's price-to-book and the engine notes that only about 57% of firms earning this return held it for a decade.

The insurer-appropriate methods cluster around and above the price. The generic non-financial methods (DCF, EV/EBITDA, FCF yield) are correctly skipped because they are not meaningful for an insurer. The methods that disagree to the downside are the conservative asset-based ones that assume the high ROE fades.

The practical read is that AFG is fairly valued to modestly attractive on its current high-teens ROE, with the answer hinging on how durable that return proves. The shareholder-return engine, special dividends plus buybacks exceeding $700 million in 2025, is the cash that pays the holder while the cycle plays out, and buybacks below the current price are accretive to book value per share. A reader is underwriting the persistence of strong specialty underwriting at today's price.

Catalysts

American Financial Group reported Q1 2026 results in late April 2026 with core net operating EPS up 36% to $2.47, a 90.3% specialty P&C combined ratio (improved 3.7 points), and a 17% core ROE. Catastrophe losses fell to 2.2 points from 4.5 a year earlier. Management guides full-year 2026 to 3% to 5% premium growth and a 92.5% combined ratio, so the next quarterly print and the trajectory of the combined ratio are the key checkpoints on whether underwriting stays this profitable.

Capital return is the defining catalyst for AFG. The company paid a $1.50 per share special dividend in February, returned nearly $260 million to shareholders in Q1 through dividends and buybacks, repurchased $60 million of stock near $127, and exceeded $700 million in total capital returns in 2025. Special dividends are declared when excess capital builds, so each declaration is both a return of cash and a signal on reserve adequacy and earnings strength. Watch for the next special-dividend announcement as the clearest catalyst.

Analyst sentiment is constructive, with a recent Buy rating and a $155 target and an average target near $142, above the current price. The swing factors are the insurance pricing cycle, reserve development, and investment income: a softening of specialty pricing, adverse reserve development, or a decline in rates that compresses float income would each pressure the high-teens ROE the valuation depends on.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive AFG report on boothcheck